Your browser doesn't support javascript.
loading
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.
Marchand, Antoine; Sarchione, Alessia; Athanasopoulos, Panagiotis S; Roy, Hélène Bauderlique-Le; Goveas, Liesel; Magnez, Romain; Drouyer, Matthieu; Emanuele, Marco; Ho, Franz Y; Liberelle, Maxime; Melnyk, Patricia; Lebègue, Nicolas; Thuru, Xavier; Nichols, R Jeremy; Greggio, Elisa; Kortholt, Arjan; Galli, Thierry; Chartier-Harlin, Marie-Christine; Taymans, Jean-Marc.
Afiliación
  • Marchand A; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Sarchione A; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Athanasopoulos PS; Department of Cell Biochemistry, University of Groningen, 9747 AG Groningen, The Netherlands.
  • Roy HB; BioImaging Center Lille, UMS 2014-US 41-PLBS, F-59000 Lille, France.
  • Goveas L; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Magnez R; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity Plasticity and Resistance to Therapies, Platform of Integrative Chemical Biology, F-59000 Lille, France.
  • Drouyer M; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Emanuele M; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Ho FY; Department of Cell Biochemistry, University of Groningen, 9747 AG Groningen, The Netherlands.
  • Liberelle M; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Melnyk P; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Lebègue N; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Thuru X; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity Plasticity and Resistance to Therapies, Platform of Integrative Chemical Biology, F-59000 Lille, France.
  • Nichols RJ; Department of Pathology, Stanford University, Stanford, CA 94305, USA.
  • Greggio E; Physiology, Genetics and Behavior Unit, Department of Biology, University of Padova, 35131 Padova, Italy.
  • Kortholt A; Department of Cell Biochemistry, University of Groningen, 9747 AG Groningen, The Netherlands.
  • Galli T; Institute of Psychiatry and Neuroscience of Paris, Université Paris Cité, INSERM U1266, F-75014 Paris, France.
  • Chartier-Harlin MC; GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, F-75014 Paris, France.
  • Taymans JM; University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.
Cells ; 11(6)2022 03 17.
Article en En | MEDLINE | ID: mdl-35326469
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article